Novel Approches In Cancer Drug Discovery
Recent advances in platform technologies and the increasing availability of biological 'big data' are providing an opportunity to systematically identify the key genes and pathways involved in tumorigenesis. The discoveries made using these new technologies may lead to novel therapeutic interventions. These approaches include the analysis of genomic sequencing data, pathway data, multi-platform data, identifying genetic interactions such as synthetic lethality and using cell line data. They revealed how big data is being used to identify novel drug targets.
- Track 1-1 Tumour Agnostic Cancer Drugs
- Track 2-2 Non Coding RNAs
- Track 3-3 Cell Surface Proteomics
- Track 4-4 Oncogenic Transcription Factors By Polyphenols